Millipore Sigma Vibrant Logo

AB1870 Anti-Osteopontin Antibody

View Products on Sigmaaldrich.com
AB1870
100 µL  
正在检索价格......
无法检索价格。
最小订购数量为倍数
Maximum Quantity is
以订单确认为准 更多信息
您节约了 ()。
 
Request Pricing
目前缺货
目前缺货
有货 
停产
少量现货
供货情况有待确认
    其余:另行通知
      其余:另行通知
      另行通知
      联系客户服务
      Contact Customer Service

      特卖

       

      联系客户服务

      概述

      Replacement Information

      重要规格表

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      H, M, RELISA, IHC, IH(P), WBRbSerumPolyclonal Antibody
      Description
      Catalogue NumberAB1870
      Brand Family Chemicon®
      Trade Name
      • Chemicon
      DescriptionAnti-Osteopontin Antibody
      Alternate Names
      • Uropontin
      • Bone sialoprotein 1
      • SPP1/CALPHA1 fusion
      • Urinary stone protein
      • bone sialoprotein I
      • osteopontin/immunoglobulin alpha 1 heavy chain constant region fusion protein
      • secreted phosphoprotein 1
      • secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1)
      • secreted phosphoprotein-1 (osteoponti,
      • bone sialoprotein)
      Background InformationOsteopontin is a single-chain polypeptide with a molecular weight of approximately 35 kDa. It is a glycoprotein first identified in osteoblasts. It is biosynthesized by a variety of tissue types including preosteoblasts, osteoblasts, osteocytes, extraosseous cells in the inner ear, brain, kidney, deciduum, placenta, odontoblasts, some bone marrow cells, hypertrophic chondrocytes, macrophages, smooth muscle, and endothelial cells. Osteopontin is overexpressed in a variety of cancers, including lung cancer, breast cancer, colorectal cancer, stomach cancer, ovarian cancer, melanoma and mesothelioma. It may contribute to kidney stone formation and both glomerulonephritis and tubulointerstitial nephritis and is also found in atheromatous plaques within arteries. Research has implicated osteopontin in excessive scar-forming and a gel has been developed to inhibit its effect.
      References
      Product Information
      FormatSerum
      HS Code3002 15 90
      Control
      • POSITIVE CONTROL: Human urine (2-5 µg/mL normal concentration).
      PresentationRabbit polyclonal antiserum in buffer containing no preservatives.
      Quality LevelMQ100
      Applications
      ApplicationThis Anti-Osteopontin Antibody is validated for use in ELISA, IH, IH(P), WB for the detection of Osteopontin.
      Key Applications
      • ELISA
      • Immunohistochemistry
      • Immunohistochemistry (Paraffin)
      • Western Blotting
      Application NotesImmunohistochemistry:
      A previous lot of this antibodu was used at a 1:1500 dilution on paraffin-embedded tissue sections.

      ELISA:
      A previous lot of this antibody was used at a 1:1000 dilution.

      Optimal working dilutions must be determined by end user.
      Biological Information
      ImmunogenSynthetic peptide corresponding to amino acids 75-90 of human osteopontin (SwissProt Accession # P10451; PSKSNESHDHMDDM DD).
      ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
      HostRabbit
      SpecificityHuman osteopontin. Does not cross react with osteonectin or human bone sialoprotein II.
      Species Reactivity
      • Human
      • Mouse
      • Rat
      Species Reactivity NoteHuman and Mouse. Expected to cross-react with rat.
      Antibody TypePolyclonal Antibody
      Entrez Gene Number
      Gene Symbol
      • SPP1
      • BNSP
      • MGC110940
      • Uropontin
      • Nephropontin
      • CIT:779436
      • osteopontin
      • SPP-1
      • BSPI
      • OPN
      • ETA-1
      Purification MethodUnpurified
      UniProt Number
      UniProt SummaryFUNCTION: SwissProt: P10451 # Acts as a cytokine involved in enhancing production of interferon-gamma and interleukin-12 and reducing production of interleukin-10 and is essential in the pathway that leads to type I immunity (By similarity).
      SIZE: 314 amino acids; 35423 Da
      SUBUNIT: Ligand for integrin alpha-V/beta-3.
      SUBCELLULAR LOCATION: Secreted.
      PTM: Extensively phosphorylated on clustered serine residues. & N- and O-glycosylated.
      DISEASE:SwissProt: P10451 # This protein plays a principal role in urinary stone formation as the stone matrix.
      SIMILARITY: SwissProt: P10451 ## Belongs to the osteopontin family.
      Molecular Weight~35 kDa
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceRoutinely evaluated by Western Blot on RAW 264.7 lysates.

      Western Blot Analysis: 1:500 dilution of this lot detected osteopontin on 10 μg of RAW 264.7 lysates.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at -20°C in undiluted aliquots from date of receipt.

      Handling Recommendations:
      Upon first thaw, and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
      Packaging Information
      Material Size100 µL
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      产品目录编号 GTIN
      AB1870 04053252476570

      Documentation

      Anti-Osteopontin Antibody MSDS

      职位

      物料安全数据表 (MSDS) 

      Anti-Osteopontin Antibody 分析证书

      标题批号
      Anti-Osteopontin - 0702052391 0702052391
      Anti-Osteopontin - 1997911 1997911
      Anti-Osteopontin - 2172681 2172681
      Anti-Osteopontin - 3046809 3046809
      Anti-Osteopontin - 3427283 3427283
      Anti-Osteopontin - 3810238 3810238
      Anti-Osteopontin - 4059346 4059346
      Anti-Osteopontin - 4105204 4105204
      Anti-Osteopontin - JC1641493 JC1641493
      Anti-Osteopontin - JC1673163 JC1673163

      参考

      参考概述应用公共医疗ID
      Serum osteopontin predicts degree of hepatic fibrosis and serves as a biomarker in patients with hepatitis C virus infection.
      Matsue, Y; Tsutsumi, M; Hayashi, N; Saito, T; Tsuchishima, M; Toshikuni, N; Arisawa, T; George, J
      PloS one  10  e0118744  2015

      显示摘要
      25760884 25760884
      Predictive usefulness of urinary biomarkers for the identification of cyclosporine A-induced nephrotoxicity in a rat model
      Carla Patrícia Carlos 1 , Nathália Martins Sonehara 2 , Sonia Maria Oliani 2 , Emmanuel A Burdmann
      Plos One  9(7)  e103660  2014

      显示摘要
      Immunohistochemistry25072153 25072153
      Expression and localisation of osteopontin and prominin-1 (CD133) in patients with endometriosis.
      D'Amico, F; Skarmoutsou, E; Quaderno, G; Malaponte, G; La Corte, C; Scibilia, G; D'Agate, G; Scollo, P; Fraggetta, F; Spandidos, DA; Mazzarino, MC
      International journal of molecular medicine  31  1011-6  2013

      显示摘要
      23545719 23545719
      Sequential application of steady and pulsatile medium perfusion enhanced the formation of engineered bone.
      Correia, C; Bhumiratana, S; Sousa, RA; Reis, RL; Vunjak-Novakovic, G
      Tissue engineering. Part A  19  1244-54  2013

      显示摘要
      Immunohistochemistry23259605 23259605
      MG63 osteoblast-like cells exhibit different behavior when grown on electrospun collagen matrix versus electrospun gelatin matrix.
      Tsai, SW; Liou, HM; Lin, CJ; Kuo, KL; Hung, YS; Weng, RC; Hsu, FY
      PloS one  7  e31200  2012

      显示摘要
      Western Blotting22319618 22319618
      Development of silk-based scaffolds for tissue engineering of bone from human adipose-derived stem cells.
      Correia, C; Bhumiratana, S; Yan, LP; Oliveira, AL; Gimble, JM; Rockwood, D; Kaplan, DL; Sousa, RA; Reis, RL; Vunjak-Novakovic, G
      Acta biomaterialia  8  2483-92  2012

      显示摘要
      Immunohistochemistry22421311 22421311
      ATF5, a possible regulator of osteogenic differentiation in human adipose-derived stem cells.
      David Tai Leong,Mohan Chothirakottu Abraham,Anurag Gupta,Thiam-Chye Lim,Fook Tim Chew,Dietmar Werner Hutmacher
      Journal of cellular biochemistry  113  2012

      显示摘要
      22442021 22442021
      Optimizing the medium perfusion rate in bone tissue engineering bioreactors.
      Grayson, WL; Marolt, D; Bhumiratana, S; Fröhlich, M; Guo, XE; Vunjak-Novakovic, G
      Biotechnology and bioengineering  108  1159-70  2011

      显示摘要
      Immunohistochemistry21449028 21449028
      Elevated Osteopontin Expression and Proliferative/Apoptotic Ratio in the Colorectal Adenoma-Dysplasia-Carcinoma Sequence.
      Valcz G, Sipos F, Krenács T, Molnár J, Patai AV, Leiszter K, Tóth K, Solymosi N, Galamb O, Molnár B, Tulassay Z
      Pathol Oncol Res  2010

      显示摘要
      20349162 20349162
      Reduced expression of biomarkers associated with the implantation window in women with endometriosis.
      Qingxiang Wei, J Benjamin St Clair, Teresa Fu, Pamela Stratton, Lynnette K Nieman, Qingxiang Wei, J Benjamin St Clair, Teresa Fu, Pamela Stratton, Lynnette K Nieman, Qingxiang Wei, J Benjamin St Clair, Teresa Fu, Pamela Stratton, Lynnette K Nieman
      Fertility and sterility  91  1686-91  2009

      显示摘要 全文本文章
      18672236 18672236

      相关产品和应用

      Related Products

      产品目录编号 描述  
      AB10910 Anti-Osteopontin Antibody 显示价格及库存情况

      种类

      Life Science Research > Antibodies and Assays > Primary Antibodies